163.60SEK+0.86%Mkt Cap: 373.25M $P/E: 30.18Today
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap373.25M $
Enterprise Value358.58M $
Revenue (TTM)70.70M $
Gross Profit49.73M $
Net Income (TTM)14.64M $
Revenue/Share2.964 USD
Last Price163.60 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees251
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)30.18
P/E (Forward)19.76
PEG—
EV/EBITDA20.15
EV/Revenue5.07
P/S5.24
P/B4.37
EPS (TTM)5.41
EPS (Forward)8.22
52W Range
117.6062% of range192.20
52W High192.20 SEK
52W Low117.60 SEK
Profitability
Gross Margin68.50%
Oper. Margin20.61%
EBITDA Margin25.17%
Profit Margin20.17%
ROE17.25%
ROA13.98%
Growth
Revenue Growth4.50%
Earnings Growth-13.20%
Cash Flow & Leverage
Operating CF19.18M $
CapEx (TTM)8.25M $
FCF Margin8.65%
FCF Yield1.64%
Net Debt-11.47M $
Net Debt/EBITDA-0.64
Balance Sheet
Debt/Equity0.03
Current Ratio3.31
Quick Ratio2.33
Book Value/Sh37.14 SEK
Cash/Share7.219 SEK
Dividends
Fwd Div Rate2.750 SEK
Trail. Div Rate2.750 SEK
Div. Yield1.70%
5Y Avg Yield1.04%
Payout Ratio50.83%
Ex-Div DateApr 29, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)175.67 SEK
Upside (mean)+7.4%
Target Range160.00 SEK – 187.00 SEK
SEK160.00+7.4% to meanSEK187.00
# Analysts3
Ownership
Shares Out.23.85M
Float19.50M
Insiders16.92%
Institutions73.72%
Technical
SMA 50143.16 (+14.3%)
SMA 200145.84 (+12.2%)
Beta0.97
S&P 52W Chg18.16%
Avg Vol (30d)22.30K
Avg Vol (10d)15.35K
Technical Indicators
RSI (14)69.7
MACD4.5660
MACD Signal3.8028
MACD Hist.+0.7631
BB Upper161.11 SEK
BB Middle149.27 SEK
BB Lower137.43 SEK
BB Width15.86%
ATR (14)4.780 SEK
Vol Ratio (20d)1.11x